Status:
COMPLETED
The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia
Lead Sponsor:
Jun Xiao
Collaborating Sponsors:
Qingdao Fifth People's Hospital
Conditions:
Hypertensive Heart Disease
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against h...
Detailed Description
To test the effect of Chinese herb against the hypertensive heart disease, we designed this randomized controlled clinical trial. 72 patients who have been diagnosed with hypertensive bradyarrhythmia ...
Eligibility Criteria
Inclusion
- \* Clinical diagnosis of hypertensive bradyarhhythmia
Exclusion
- With other elementary diseases
- With pregnant
- With receiving other treatment within past half year from the beginning of trial.
Key Trial Info
Start Date :
January 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04505228
Start Date
January 20 2020
End Date
June 20 2020
Last Update
August 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The fifth Qingdao people's hospital
Qingdao, Shandong, China, 266000